• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Infinium Share Price

    Infinium Pharmachem Share PriceInfinium Pharmachem

    Small Cap Result
    ₹264.1
    -13.9 (-5%)
    As on 01 October, 2023 | 20:39 BSE: NSE: INFINIUMISIN: INE0MRE01011
    Bonus

    Infinium Pharmachem Performance

    Day Range

    • Low 264.1
    • High 264.2
    264.1

    52 Week Range

    • Low 70.75
    • High 315.7
    264.1
    • Open Price264.1
    • Previous Close278
    • Volume34000

    Start SIP in Infinium Pharmachem

    Start SIP

    Infinium Pharmachem Share Price

    • Over 1 Month 0.23%
    • Over 3 Month 90.34%

    Infinium Pharmachem Key Statistics

    P/E Ratio
    PEG Ratio
    Market Cap Cr 368
    Price to Book Ratio 15.5
    EPS 6.6
    Dividend 0
    Relative Strength Index 49.39
    Money Flow Index 52.65
    MACD Signal 18.31
    Average True Range 14.13

    Infinium Pharmachem Investment Rating

    • Master Rating:

    • Infinium Pharmachem Ltd has an operating revenue of Rs. 322.72 Cr. on a trailing 12-month basis. An annual revenue growth of 16% is outstanding, Pre-tax margin of 11% is healthy, ROE of 42% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 12% and 51% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 72 which is a FAIR score but needs to improve its earnings, a RS Rating of 97 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 2 indicates it belongs to a strong industry group of Comml Svcs-Healthcare and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Infinium Pharmachem Financials
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 10375
    Operating Expenses Annual Cr 8665
    Operating Profit Annual in Cr 159
    Depreciation Cr 11
    Interest Annual Cr 32
    Tax Annual Cr 32
    Net Profit Annual Cr 96
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 9
    Cash from Investing Activity Annual Cr -7
    Cash from Financing Annual Activity Cr -2
    Net Cash Flow Annual Cr 0
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 2213
    Fixed Assets Annual Cr 1612
    Total Non Current Assets Annual Cr 1615
    Total Current Assets Annual Cr 4434
    Total Assets Annual Cr 6049
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 43123
    ROE Annual % 4244
    ROCE Annual % 5235
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1613
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 116100
    Operating Expenses Annual Cr 9889
    Operating Profit Annual in Cr 1610
    Depreciation Cr 11
    Interest Annual Cr 32
    Tax Annual Cr 32
    Net Profit Annual Cr 96
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 12
    Cash from Investing Activity Annual Cr -7
    Cash from Financing Annual Activity Cr -2
    Net Cash Flow Annual Cr 3
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 2314
    Fixed Assets Annual Cr 1913
    Total Non Current Assets Annual Cr 1915
    Total Current Assets Annual Cr 5144
    Total Assets Annual Cr 7159
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 47137
    ROE Annual % 4244
    ROCE Annual % 4738
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1511

    Infinium Pharmachem Technicals

    EMA & SMA

    Current Price
    ₹264.1
    -13.9 (-5%)
    • Bullish Moving Average
    • ___
    • 4
    • Bearish Moving Average
    • ___
    • 9
    • 20 Day
    • ₹274.03
    • 50 Day
    • ₹239.58
    • 100 Day
    • ₹190.4
    • 200 Day
    • ₹
    • 20 Day
    • ₹272.93
    • 50 Day
    • ₹234.43
    • 100 Day
    • ₹186.51
    • 200 Day
    • ₹

    Infinium Pharmachem Resistance and Support

    PIVOT
    ₹264.14
    Resistance
    First Resistance ₹264.17
    Second Resistance ₹264.24
    Third Resistance ₹264.27
    RSI 49.39
    MFI 52.65
    MACD Single Line 18.31
    MACD 14.96
    Support
    First Resistance ₹264.07
    Second Resistance ₹264.04
    Third Resistance ₹263.97

    Infinium Pharmachem Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 34,000 3,200,080 94.12
    Week 14,800 1,359,972 91.89
    1 Month 11,286 1,014,247 89.87
    6 Month 28,661 2,387,772 83.31

    Infinium Pharmachem Result Highlights

    Infinium Pharmachem Synopsis

    NSE-Comml Svcs-Healthcare

    Infinium Pharmachem belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 101.31 Cr. and Equity Capital is Rs. 5.08 Cr. for the Year ended 31/03/2023. Infinium Pharmachem Ltd. is a Public Limited Listed company incorporated on 21/11/2003 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24231GJ2003PLC043218 and registration number is 043218.
    Market Cap 368
    Sales 101
    Shares in Float 1.39
    No of funds
    Yield
    Book Value 12.37
    U/D Vol ratio 1.5
    LTDebt / Equity
    Alpha 1.35
    Beta -1.33

    Infinium Pharmachem

    Owner Name

    Infinium Pharmachem Management

    Name Designation
    Mr. Sanjaykumar Viththalbhai Patel Chairman & Managing Director
    Mr. Pravin Bhadabhai Madhani Executive Director
    Mr. Mitesh Lavjibhai Chikhaliya Executive Director
    Mr. Keyur Jagdishchandra Shah Independent Director
    Mr. Tarun Ratilal Dobariya Independent Director
    Mr. Vaishakhi Ambrishbhai Shukla Independent Director

    Infinium Pharmachem Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Infinium Pharmachem Corporate Action

    Date Purpose Remarks
    2023-08-02 Bonus issue
    2023-05-17 Audited Results
    Date Purpose Remarks
    2023-09-13 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-.
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Infinium Pharmachem FAQs

    What is Share Price of Infinium Pharmachem ?

    Infinium Pharmachem share price is ₹264 As on 01 October, 2023 | 20:25

    What is the Market Cap of Infinium Pharmachem ?

    The Market Cap of Infinium Pharmachem is ₹367.5 Cr As on 01 October, 2023 | 20:25

    What is the P/E ratio of Infinium Pharmachem ?

    The P/E ratio of Infinium Pharmachem is As on 01 October, 2023 | 20:25

    What is the PB ratio of Infinium Pharmachem ?

    The PB ratio of Infinium Pharmachem is 15.5 As on 01 October, 2023 | 20:25

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.